Product

RabAvert

2 clinical trials

2 indications

Indication
Virus Diseases
Clinical trial
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of RBI-4000 in Healthy Volunteers
Status: Active (not recruiting), Estimated PCD: 2025-04-14